Overall Status

Completed (12)

Recruiting (11)

Active, not recruiting (3)

Unknown status (1)

Phase

phase 1 (10)

phase 1/phase 2 (5)

phase 2 (5)

n/a (3)

phase 4 (1)

Collaborator

National Cancer Institute (NCI) (8)

Genentech, Inc. (2)

SCRI Development Innovations, LLC (2)

ICON plc (1)

Massachusetts General Hospital (1)

National Center for Complementary and Integrative Health (NCCIH) (1)

Novartis (1)

Sanofi (1)

Texas Oncology Cancer Center (1)

Study Documents

Intervention Type

drug (19)

other (4)

biological (3)

genetic (3)

procedure (3)

radiation (3)

behavioral (2)

device (1)

Funder Type

Industry (16)

Other (11)

Study Type

Interventional (24)

Observational (3)

Esophageal Cancer

Showing NaN - NaN of 27

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Esophageal Cancer, Gastric Cancer Trial in United States (FOLFIRI regimen, fluorouracil, irinotecan HCl)

Unknown status

Esophageal Cancer
Gastric Cancer

FOLFIRI regimen
+3 more

Chicago, Illinois
+3 more

Dec 18, 2013

Esophageal Cancer Trial in Puerto Rico, South Africa, United States (carboplatin, docetaxel)

Completed

Esophageal Cancer

Scottsdale, Arizona
+73 more

Aug 22, 2013